P.S. Mitrou
- Hematology top 5%
- Acute Myeloid Leukemia Research 12
- Hematopoietic Stem Cell Transplantation 5
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 4
-
- Lymphoma Diagnosis and Treatment 8
-
- Acute Lymphoblastic Leukemia research 5
-
- Lung Cancer Treatments and Mutations 5
-
- Bioactive Compounds and Antitumor Agents 3
-
- Neuroendocrine Tumor Research Advances 3
- Co-authors
- D. HoelzerLothar BergmannEckhart WeidmannJürgen BriegerKlaus FenchelBernhard JahnUlrich MaurerSimone Boehrer
- Partner nations
- GermanyUnited KingdomRomania
In The Last Decade
P.S. Mitrou
38 papers receiving 525 citations
Peers
Comparison fields: 5 of 62
- Hematology 161
- Genetics 117
- Pathology and Forensic Medicine 99
- Oncology 147
- Public Health, Environmental and Occupational Health 133
Countries citing papers authored by P.S. Mitrou
This map shows the geographic impact of P.S. Mitrou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.S. Mitrou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.S. Mitrou more than expected).
Fields of papers citing papers by P.S. Mitrou
This network shows the impact of papers produced by P.S. Mitrou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.S. Mitrou. The network helps show where P.S. Mitrou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside P.S. Mitrou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 1 | |
| 2 | 2005 | 4 | |
| 3 | 2005 | 13 | |
| 4 | 2004 | 3 | |
| 5 | In vitro induction of apoptosis of neoplastic cells in low-grade non-Hodgkin's lymphomas using combinations of established cytotoxic drugs with bendamustine. | 2001 | 57 |
| 6 | 1997 | 2 | |
| 7 | Paclitaxel and simultaneous radiation in locally advanced stage IIIA/B non-small cell lung cancer: a clinical phase I study. | 1996 | 5 |
| 8 | 1995 | 5 | |
| 9 | 1995 | 5 | |
| 10 | 1995 | 1 | |
| 11 | Cytokines in cancer therapy | 1994 | 1 |
| 12 | 1993 | 23 | |
| 13 | 1993 | 78 | |
| 14 | 1990 | 4 | |
| 15 | 1988 | 1 | |
| 16 | 1988 | 9 | |
| 17 | 1986 | 3 | |
| 18 | 1985 | 16 | |
| 19 | 1978 | 1 | |
| 20 | 1974 | 6 |
About P.S. Mitrou
P.S. Mitrou is a scholar working on Hematology, Toxicology and Genetics, having authored 40 papers that have together received 541 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (12 papers), Lymphoma Diagnosis and Treatment (8 papers), Acute Lymphoblastic Leukemia research (5 papers), Hematopoietic Stem Cell Transplantation (5 papers), Lung Cancer Treatments and Mutations (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Bioactive Compounds and Antitumor Agents (3 papers) and Neuroendocrine Tumor Research Advances (3 papers). The work is most often cited by research in Hematology (161 citations), Genetics (117 citations) and Pathology and Forensic Medicine (99 citations). P.S. Mitrou has collaborated with scholars based in Germany, United Kingdom and Romania. Frequent co-authors include D. Hoelzer, Lothar Bergmann, Eckhart Weidmann, Jürgen Brieger, Klaus Fenchel, Bernhard Jahn, Ulrich Maurer, Simone Boehrer, Kai Uwe Chow and Lars Bergmann. Their work appears in journals such as Annals of Hematology, Annals of Oncology, Acta Haematologica, Cancer Treatment Reviews and Pharmacological Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.